Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dan'ge Fentong Capsules is a Traditional Chinese Medicine (TCM) candidate developed by the Sichuan Academy of Chinese Medicine Sciences for the treatment of diabetic peripheral neuropathy (DPN). The formulation is specifically designed to address the TCM pattern of 'yin deficiency and blood stasis' (yin xu xue yu), which is commonly associated with chronic diabetic complications. As a botanical product, it likely exerts therapeutic effects through multi-target pathways, including the improvement of microcirculation, reduction of oxidative stress, and neuroprotection. The drug is currently in Phase III clinical development in China, with trials (such as CTR20243261) evaluating its efficacy and safety in patients with DPN.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dan'ge Fentong Capsules.